Marshall S. Stanton's most recent trade in Artivion Inc was a trade of 2,423 Common Stock done at an average price of $37.6 . Disclosure was reported to the exchange on Feb. 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 37.59 per share. | 23 Feb 2026 | 2,423 | 43,180 (0%) | 0% | 37.6 | 91,076 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 35.69 per share. | 23 Feb 2026 | 1,259 | 41,921 (0%) | 0% | 35.7 | 44,937 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 24.30 per share. | 31 Dec 2025 | 534 | 45,287 (0%) | 0% | 24.3 | 12,977 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 26.14 per share. | 31 Dec 2025 | 316 | 45,603 (0%) | 0% | 26.1 | 8,260 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 27,075 | 0 | - | - | Stock Options (Right to buy) | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.03 per share. | 21 Nov 2025 | 27,075 | 71,828 (0%) | 0% | 11.0 | 298,637 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.44 per share. | 21 Nov 2025 | 20,301 | 65,054 (0%) | 0% | 18.4 | 374,350 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 20,301 | 0 | - | - | Stock Options (Right to buy) | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 44.91 per share. | 21 Nov 2025 | 18,705 | 53,123 (0%) | 0% | 44.9 | 840,042 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 44.92 per share. | 21 Nov 2025 | 14,586 | 50,468 (0%) | 0% | 44.9 | 655,189 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 45.35 per share. | 21 Nov 2025 | 8,370 | 44,753 (0%) | 0% | 45.3 | 379,538 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 45.35 per share. | 21 Nov 2025 | 5,715 | 44,753 (0%) | 0% | 45.3 | 259,152 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 44.14 per share. | 20 Nov 2025 | 11,888 | 44,753 (0%) | 0% | 44.1 | 524,736 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 2,033 | 20,301 | - | - | Stock Options (Right to buy) | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 44.31 per share. | 20 Nov 2025 | 2,033 | 44,753 (0%) | 0% | 44.3 | 90,092 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.44 per share. | 20 Nov 2025 | 2,033 | 46,786 (0%) | 0% | 18.4 | 37,489 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 44.28 per share. | 20 Nov 2025 | 1,355 | 44,753 (0%) | 0% | 44.3 | 59,997 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.03 per share. | 20 Nov 2025 | 1,355 | 46,108 (0%) | 0% | 11.0 | 14,946 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 1,355 | 27,075 | - | - | Stock Options (Right to buy) | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 45.86 per share. | 13 Nov 2025 | 4,993 | 56,641 (0%) | 0% | 45.9 | 228,969 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 44.62 per share. | 10 Nov 2025 | 2,566 | 61,634 (0%) | 0% | 44.6 | 114,492 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 44.02 per share. | 27 Aug 2025 | 18,200 | 64,200 (0%) | 0% | 44.0 | 801,219 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.03 per share. | 27 Aug 2025 | 18,200 | 82,400 (0%) | 0% | 11.0 | 200,746 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2025 | 18,200 | 0 | - | - | Stock Option (Right to Buy) | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 29.50 per share. | 17 Jun 2025 | 13,764 | 65,436 (0%) | 0% | 29.5 | 406,038 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 29.50 per share. | 17 Jun 2025 | 1,236 | 64,200 (0%) | 0% | 29.5 | 36,462 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 28.42 per share. | 13 Jun 2025 | 14,306 | 81,026 (0%) | 0% | 28.4 | 406,601 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 28.46 per share. | 13 Jun 2025 | 8,747 | 96,585 (0%) | 0% | 28.5 | 248,953 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 28.43 per share. | 13 Jun 2025 | 1,826 | 79,200 (0%) | 0% | 28.4 | 51,909 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 28.47 per share. | 13 Jun 2025 | 1,253 | 95,332 (0%) | 0% | 28.5 | 35,669 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 29.13 per share. | 09 May 2025 | 5,737 | 110,143 (0%) | 0% | 29.1 | 167,120 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 29.13 per share. | 09 May 2025 | 4,811 | 105,332 (0%) | 0% | 29.1 | 140,145 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 19,240 | 117,483 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 24.80 per share. | 06 Mar 2025 | 1,603 | 115,880 (0%) | 0% | 24.8 | 39,761 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 18,398 | 98,243 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 27.31 per share. | 24 Feb 2025 | 2,299 | 82,233 (0%) | 0% | 27.3 | 62,776 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 27.31 per share. | 24 Feb 2025 | 1,246 | 79,845 (0%) | 0% | 27.3 | 34,023 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 27.31 per share. | 24 Feb 2025 | 672 | 81,091 (0%) | 0% | 27.3 | 18,350 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 27.31 per share. | 24 Feb 2025 | 470 | 81,763 (0%) | 0% | 27.3 | 12,834 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 15.20 per share. | 31 Dec 2024 | 855 | 84,151 (0%) | 0% | 15.2 | 12,996 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 21.63 per share. | 31 Dec 2024 | 381 | 84,532 (0%) | 0% | 21.6 | 8,241 | Common Stock |
| Artivion Inc | Marshall Stanton S. | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 20.39 per share. | 20 Mar 2024 | 2,183 | 83,296 (0%) | 0% | 20.4 | 44,511 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 5,724 | 86,944 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 5,724 | 86,985 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 18.72 per share. | 01 Mar 2024 | 1,506 | 85,438 (0%) | 0% | 18.7 | 28,195 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 18.72 per share. | 01 Mar 2024 | 1,506 | 85,479 (0%) | 0% | 18.7 | 28,195 | Common Stock |
| Artivion Inc | S. Marshall Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 19.83 per share. | 27 Feb 2024 | 465 | 81,220 (0%) | 0% | 19.8 | 9,223 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 19.83 per share. | 27 Feb 2024 | 465 | 81,261 (0%) | 0% | 19.8 | 9,223 | Common Stock |
| Artivion Inc | S. Stanton Marshall | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 14,800 | 68,703 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Stanton Marshall S. | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 10,644 | 83,133 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 10,644 | 83,157 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | S. Marshall Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 5,386 | 74,089 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 5,386 | 74,089 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Stanton S. Marshall | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 20.27 per share. | 23 Feb 2024 | 1,600 | 72,489 (0%) | 0% | 20.3 | 32,434 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 20.27 per share. | 23 Feb 2024 | 1,576 | 72,513 (0%) | 0% | 20.3 | 31,947 | Common Stock |
| Artivion Inc | Marshall Stanton S. | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 20.27 per share. | 23 Feb 2024 | 1,448 | 81,685 (0%) | 0% | 20.3 | 29,353 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 20.27 per share. | 23 Feb 2024 | 1,431 | 81,726 (0%) | 0% | 20.3 | 29,008 | Common Stock |
| Artivion Inc | S. Marshall Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 10.30 per share. | 31 Dec 2023 | 1,261 | 53,338 (0%) | 0% | 10.3 | 12,991 | Common Stock |
| Artivion Inc | Stanton S. Marshall | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 14.61 per share. | 31 Dec 2023 | 565 | 53,903 (0%) | 0% | 14.6 | 8,255 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 3,663 | 52,984 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 13.41 per share. | 01 Mar 2023 | 907 | 52,077 (0%) | 0% | 13.4 | 12,165 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 7,440 | 50,482 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 3,770 | 44,218 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 23 Feb 2023 | 1,176 | 43,042 (0%) | 0% | 12.9 | 15,215 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 23 Feb 2023 | 1,161 | 49,321 (0%) | 0% | 12.9 | 15,021 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 16.05 per share. | 31 Dec 2022 | 810 | 40,005 (0%) | 0% | 16.0 | 12,999 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 10.30 per share. | 31 Dec 2022 | 443 | 40,448 (0%) | 0% | 10.3 | 4,564 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 46,630 | 46,630 | - | - | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 19,447 | 39,195 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 22,334 | 22,334 | - | - | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 8,406 | 19,748 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 2,603 | 12,114 (0%) | 0% | 0 | Common Stock | |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.50 per share. | 17 Feb 2022 | 772 | 11,342 (0%) | 0% | 17.5 | 13,510 | Common Stock |
| Artivion Inc | Marshall S. Stanton | SVP, Clinical & MD Affair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 8,511 | 9,511 (0%) | 0% | 0 | Common Stock |